Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ACRBP - Saturated fatty acid rich diet effect on risk of metabolic syndrome: adipose tissue
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACRBP - Interleukin-3 effect on acute myeloid leukemia patient mononuclear cells: time course
ACRBP - Glycogen synthase kinase 3 inhibitor effect on MLL leukemia cells
ACRBP - Breast lipotransfer white adipose tissue CD34+ cells
ACRBP - Malawian children with mild malaria following an episode of severe malaria: peripheral whole blood
ACRBP - Saracatinib-sensitive versus -resistant, PIK3CA mutant colorectal cancer xenografts
ACRBP - Multiple sclerosis: peripheral blood mononuclear cells
ACRBP - Severe pandemic H1N1 influenza effect on peripheral blood: time course
ACRBP - First, second and third trimester pregnancy: maternal cell-free plasma
ACRBP - Bone marrow microenvironment effect on imatinib-treated chronic myeloid leukemia CD34+ cells
ACRBP - Type 2 diabetic and hyperglycemic pancreatic islets
ACRBP - Acute Picornavirus-induced exacerbation in asthmatic children: nasal lavage cells
ACRBP - Modified natural and stimulated in vitro fertilization cycles: cumulus cells
ACRBP - Hemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
ACRBP - Carotid artery atheroma
ACRBP - In vitro differentiated amniotic-fluid kidney progenitor cell-podocytes
ACRBP - Interleukin-21 effect on STAT3-deficient naïve B cells from autosomal dominant hyper IgE syndrome patients
ACRBP - HIV envelope protein gp120 effect on activated B cells from healthy donors: time course
ACRBP - Acute myeloid leukemia cell line Kasumi-1 response to dasatinib treatment and withdrawal
ACRBP - Xenograft ovarian tumor response to anti-cancer therapeutic MT19: time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on